ICD-10-CM Code | ICD-10-CM Description |
---|---|
C50.412 | Primary Breast, UOQ, Female, Left |
C77.3 | Secondary, Malignant Neoplasm Axilla and Upper Limb Lymph Nodes |
Secondary and unspecified malignant neoplasm of lymph node, unspecified. C77. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Secondary malignant neoplasm of breast The 2022 edition of ICD-10-CM C79. 81 became effective on October 1, 2021.
ICD-10 | Malignant neoplasm of unspecified site of unspecified female breast (C50. 919)
2022 ICD-10-CM Diagnosis Code C77. 3: Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes.
ICD-10-CM Code for Secondary malignant neoplasm of unspecified site C79. 9.
When breast cancer spreads to an area farther from where it started to another part of the body, doctors say that the cancer has “metastasized.” They call the area of spread a “metastasis,” or use the plural of “metastases” if the cancer has spread to more than 1 area. The disease is called metastatic breast cancer.
2022 ICD-10-CM Diagnosis Code D05. 12: Intraductal carcinoma in situ of left breast.
51: Secondary malignant neoplasm of bone.
2022 ICD-10-CM Diagnosis Code N63: Unspecified lump in breast.
Biopsy or excision of lymph node(s) is an inherent part of CPT code 19302. To report the work associated with the intraoperative identification of the sentinel node, report add-on code 38900.Nov 2, 2011
2022 ICD-10-PCS Procedure Code 07B60ZX.
Anatomical terminology. The periaortic lymph nodes (also known as lumbar) are a group of lymph nodes that lie in front of the lumbar vertebrae near the aorta. These lymph nodes receive drainage from the gastrointestinal tract and the abdominal organs.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
Sarcoma is a malignancy that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a malignancy that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood.